Unique ID issued by UMIN | UMIN000025211 |
---|---|
Receipt number | R000028998 |
Scientific Title | Clinical research of the left ventricular assist device with post-auricular connector |
Date of disclosure of the study information | 2017/02/01 |
Last modified on | 2016/12/10 11:16:18 |
Clinical research of the left ventricular assist device with post-auricular connector
Clinical research of Jarvik-PA
Clinical research of the left ventricular assist device with post-auricular connector
Clinical research of Jarvik-PA
Japan |
severe heart failure
Cardiology | Cardiovascular surgery |
Others
NO
This study is designed to evaluate the 6-month safety of the Jarvik 2000 Left Ventricular Assist System (LVAS) with Post-Auricular Connector, in patients with end-stage left ventricular failure who are ineligible for cardiac transplantation and have been demonstrated to be refractory to optimal medical therapy.
Safety
Drive-line infection 6-month after the implantation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
The study will utilize the Jarvik 2000 LVAS with Post- Auricular Connector in patients with New York Heart Association Class IIIb and IV end-stage left ventricular failure who are ineligible for cardiac transplantation.
20 | years-old | <= |
Not applicable |
Male and Female
1) patient who understands the purpose of the study and consents the entry.
2) 20 years old or older.
3) patient and his family understand and consent end-of-life care.
4) severe heart failure patient who needs heart transplantation but is ineligible for it.
5) New York Heart Association Class IIIb and IV end-stage left ventricular failure.
6) patient who has undergone maximum optimal medical therapy but has been demonstrated to be refractory to it.
7) BSA 1.2-2.3m2
8)patient who has a care-giver.
1) J-macs profile 1
2) patients who have uncontrollable severe infections.
3) the prognosis of other diseases is less than 3 years.
4) patients who underwent open chest surgery less than 2 weeks before.
5) patients who has contraindication of LVAD implantation due to aortic or ventricular aneurysm, or VSD etc(exclude the cases who can undergo the surgery at the same time).
6) patients who has moderate AR (exclude the cases who can undergo the surgery at the same time).
7) patients with severe cerebral or phsychological disease who can't control LVAD.
8) patients who has a tendency to bleed.
9) pregnant or who wants to became pregnant
10)cirrhosis (Child C)
11) patients who refuse transfusion.
12) patients who has an allergy to bovine products.
13) patients who are participating other clinical studies which affects this study.
14) patients who are considered to be inappropriate
to join this study by the researcher.
6
1st name | |
Middle name | |
Last name | Yoshiki Sawa |
Osaka University hospital
Department of Cardiovascular Surgery
2-15, Yamadaoka, Suita, Osaka
0668793154
sawa-p@surg1.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Ryohei Matsuura |
Osaka University hospital
Department of Cardiovascular Surgery
2-15, Yamadaoka, Suita, Osaka
0668793154
r-matsuura@surg1.med.osaka-u.ac.jp
Osaka University hospital
self funding
Self funding
NO
2017 | Year | 02 | Month | 01 | Day |
Unpublished
Preinitiation
2017 | Year | 01 | Month | 05 | Day |
2017 | Year | 02 | Month | 01 | Day |
2016 | Year | 12 | Month | 10 | Day |
2016 | Year | 12 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028998